BMY

Bristol-Myers Squibb
D

BMY

Arincen68/100B

Bristol-Myers Squibb shares outstanding 1987–2026

Bristol-Myers Squibb had 2,044,085,831 shares outstanding on 14 November 2026. Bristol-Myers Squibb had 2.05B diluted shares on average over the last twelve months, up 0.4% on the twelve months before. In fiscal year 2025 the average was 2.04B.

Last updated 12 Nov 2026 · Next report 4 Feb 2027

Shares outstanding

Change on the year

Fiscal yearPeriod endingShares outstandingChange on the yearBasic shares
TTM30 Sept 20262.05B+0.44%2.04B
FY202531 Dec 20252.04B+0.69%2.04B
FY202431 Dec 20242.03B-2.45%2.03B
FY202331 Dec 20232.08B-3.17%2.07B
FY202231 Dec 20222.15B-4.41%2.13B
FY202131 Dec 20212.25B-0.58%2.22B
FY202031 Dec 20202.26B+31.89%2.26B
FY201931 Dec 20191.71B+4.58%1.71B
FY201831 Dec 20181.64B-0.91%1.63B
FY201731 Dec 20171.65B-1.67%1.65B
FY201631 Dec 20161.68B+0.06%1.67B
FY201531 Dec 20151.68B+0.54%1.67B
FY201431 Dec 20141.67B+0.48%1.66B
FY201331 Dec 20131.66B-1.54%1.64B
FY201231 Dec 20121.69B-1.69%1.67B
FY201131 Dec 20111.72B-0.58%1.70B
FY201031 Dec 20101.73B-12.69%1.71B
FY200931 Dec 20091.98B-1.15%1.97B
FY200831 Dec 20082.00B+1.06%1.98B
FY200731 Dec 20071.98B+0.87%1.97B
FY200631 Dec 20061.96B-1.01%1.96B
FY200531 Dec 20051.98B+0.35%1.95B
FY200431 Dec 20041.98B+1.33%1.94B
FY200331 Dec 20031.95B-3.28%1.94B
FY200231 Dec 20022.02B+2.60%2.00B
FY200131 Dec 20011.97B-1.60%1.94B
FY200031 Dec 20002.00B-1.48%1.97B
FY199931 Dec 19992.03B-0.20%1.98B
FY199831 Dec 19982.03B-0.54%1.99B
FY199731 Dec 19972.04B+0.29%1.99B
FY199631 Dec 19962.04B+0.20%2.01B
FY199531 Dec 19952.03B-0.20%2.02B
FY199431 Dec 19942.04B-1.27%2.04B
FY199331 Dec 19932.06B+0.90%2.06B
FY199231 Dec 19922.04B-1.59%2.04B
FY199131 Dec 19912.08B-0.20%2.08B
FY199031 Dec 19902.08B+0.29%2.08B
FY198931 Dec 19892.08B-0.72%2.08B
FY198831 Dec 19882.09B-2.15%2.09B
FY198731 Dec 19872.14B—2.14B

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,Net income,EPS,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about Bristol-Myers Squibb's shares

Source: Financial Modeling PrepVerified against SEC filings